Share
KPI Health Care Limited v Unipharma Limited & Another (Miscellaneous Application 1328 of 2022) [2023] UGCommC 229 (21 February 2023)
- Citation
- [2023] UGCommC 229
- Status
- Judgment
- Jurisdiction
- Uganda
- Court
- Commercial Court of Uganda
- Panel
- Anna B. Mugenyi, J
- Case number
- Miscellaneous Application 1328 of 2022
- Language
- English
More details
- Court
- Commercial Court of Uganda
- Panel
- Anna B. Mugenyi, J
- Case number
- Miscellaneous Application 1328 of 2022
- Language
- English
On this page
Professional case brief
Research organized from the available case record
01
Holding and result
The existence of a clear and binding arbitration clause in the Contract Manufacture Agreement between the parties requires the court to refer the dispute to arbitration. The pleadings demonstrate a genuine dispute regarding the quality and regulatory compliance of the goods supplied, which falls squarely within the scope of the arbitration agreement. The court's role is limited to enforcing the parties' agreement to arbitrate, and all issues, including costs, are to be determined by the arbitral tribunal. The civil suit lapses and the matter is closed, subject to any appellate or supervisory jurisdiction as provided under the Arbitration and Conciliation Act.
Court disposition
referred to arbitration
Orders
- The entire dispute is referred to arbitration in accordance with the Contract Manufacture Agreement.
- Civil Suit 701 of 2022 lapses as the dispute is now subject to arbitration.
- Costs occasioned by commencing the suit in court shall be determined by the arbitral tribunal.
- The court file is closed.
02
Material facts
Parties
KPI Health Care Limited
ApplicantUnipharma Limited
RespondentUnipharma FC (Malaysia) SDN BHD
RespondentAmounts and remedies
- Contract Balance Claimed: USD 43,555
- Contract Balance Disputed: USD 45,333
03
Procedural history
Posture
Miscellaneous Application / Referral to Arbitration
04
Questions and positions
Legal issues
- 01
Whether the dispute between the parties falls within the scope of the arbitration clause in the Contract Manufacture Agreement.
- 02
Whether there exists a dispute regarding the quality and regulatory compliance of SUPAVITAM supplied under the contract.
- 03
Whether the court should refer the matter to arbitration in light of the parties' agreement.
Party arguments
- Applicant
- The applicant asserts that a dispute exists as to whether the SUPAVITAM supplied by the respondents met the regulatory requirements and was of good quality as agreed in the contract. The applicant contends that the product did not contain some components as stated on its label and certificate of analysis, rendering it unsellable and thus the claimed contract balance is not due.
- Respondent
- The respondents argue that there is no dispute to be referred for arbitration, asserting that the SUPAVITAM supplied met regulatory requirements as evidenced by importation certificates. They further contend that any quality issues should have been raised within 21 days, which the applicant failed to do, and seek recovery of the outstanding contract balance.
05
Court’s reasoning
Legal principles
- 01
Printing & Numerical Registering Company Vs Sampson (1875) 19 EQ 462; Stockloser v Johnson (1954) 1 ALL ER 640
Courts must enforce arbitration agreements freely entered into by parties, referring disputes covered by such clauses to arbitration.
- 02
Arbitration and Conciliation Act (Cap 4), Sections 5 and 9
Where a contract contains an arbitration clause, courts should stay proceedings and refer the dispute to arbitration unless the clause is inapplicable.
- 03
Arbitration and Conciliation Act (Cap 4)
The arbitral tribunal has the authority to determine costs occasioned by the commencement of suit in court when the matter is referred to arbitration.
06
Ratio, limits and disposition
Ratio decidendi
The existence of a clear and binding arbitration clause in the Contract Manufacture Agreement between the parties requires the court to refer the dispute to arbitration. The pleadings demonstrate a genuine dispute regarding the quality and regulatory compliance of the goods supplied, which falls squarely within the scope of the arbitration agreement. The court's role is limited to enforcing the parties' agreement to arbitrate, and all issues, including costs, are to be determined by the arbitral tribunal. The civil suit lapses and the matter is closed, subject to any appellate or supervisory jurisdiction as provided under the Arbitration and Conciliation Act.
Obiter and limits
- Having referred the matter to arbitration, the court finds it unnecessary to address other issues raised by the respondents at this stage.
- The file shall be closed accordingly, with any further intervention limited to appellate or supervisory matters as per statute.
Court disposition
referred to arbitration
- The entire dispute is referred to arbitration in accordance with the Contract Manufacture Agreement.
- Civil Suit 701 of 2022 lapses as the dispute is now subject to arbitration.
- Costs occasioned by commencing the suit in court shall be determined by the arbitral tribunal.
- The court file is closed.
Source and reliance status
Commercial Court of Uganda
This page organises the available record for research. Confirm quotations, current status, and subsequent treatment against the official source before relying on the case.
Judgment reading view
Judgment text
The complete available source text.
Commercial Court of Uganda
Judgment
THE REPUBLIC OF UGANDA
IN THE HIGH COURT OF UGANDA AT KAMPALA (COMMERCIAL DIVISION)
MISC. APPLICATION NO. 1328OF 2022 (ARISING FROM CrVrL SUrT NO. 07Ot OF 2022) KPI HEALTH CARE LIMITED : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : APPLICANT
VERSUS
UNIPHARMA LIMITED
J
?
UNIPHARMA FC (MALAYSIA) SDN BHD: : : : : : : : : : : : : : : : : : : Rf, SPONDENTS BEFORE: HON. LADY JUSTICE ANNA B. MUGENYI
RULING
I have read the pleadings and considered the written submissions of the Applicant in this matter.
The Applicant brought to the attention of this court the existence of an arbitral agreement /clause between the parties i.e. in the Contract Manufacture Agreement signed by the parties on 31912018.
I have read the arbitration agreement in clause l7 of the said Contract Manufacture Agreement and the same is very clear and self-explanatory. Clearly any disputes arising under the Agreement in issue are to be referred for arbitration.
The contention of the Respondents, however, appears to be that there is no dispute to be referred for arbitration for reasons laid out in the submissions of counsel for the respondents (see paragraphs 9 (l) to (12), 10,11,12, 14, l5 and l6); and funher that the SUPAVITAM supplied to the Applicant met the regulatory requirements because the said consignments were issued with importation certificates at the time of importation and that any issues regarding quality of the consignments in issue should have been raised within 21 days by the Applicant which was not done.
N,"(,
The Applicant on the other hand contends that there is a dispute as to whether the SUPAVITAM supplied by the Respondents to the Applicant met the requisite regulatory requirements and was of good quality as agreed in the Agreement in issue.
I have had an opportunity to look at the plaint and written statement of defense of the respective parties on court record. While the Respondents filed the main suit from which this matter arose seeking recovery of USD 43,555 being the outstanding balance on the contract price for the supply of SUPAVITAM, the Applicant contends, in their defense, that the said sum of monies is not due to the Respondents as the SUPAVITAM supplied to it did not contain some of the components as stated on its label and the certificate of analysis provided by the Respondents and as such could not be sold (see paragraph 5 (i) to (ix) and 6 of the written statement of defense).
To this Court and from the pleadings of the parties herein, clearly there is a dispute between the parties as to whether the SUPAVITAM supplied by the Respondents was of good quality to entitle the Respondents payment of USD 45,333 by the Applicant as the balance on the contract sum claimed by the Respondents in the plaint.
The parties freely agreed to the arbitral clause above mentioned and it is the duty of this Court to enforce the same (see Printing & Numerical Registering Company Vs Sampson (1875) 19 EQ 462 & Stockloser versus Johnson (1954) 1 ALL ER $640$ ).
The Arbitration and Conciliation Act (Cap 4) and several case law are instructive on the role of courts where a matter is the subject of an Arbitration clause/agreement (see Section 9 and 5 of the said Act; and British American Tobacco Uganda Ltd versus Lira Tobacco Stores HCMA 310/2013; Daniel Delestre & Others versus Hits Telecom HCMA 310/2013 inter alia).
In the premises and given the existence of a clear arbitration clause or agreement that was willingly endorsed / entered into by the parties as seen above; the present matter is referred for Arbitration proceedings to ensue.
As guided by the aforementioned authorities; Civil Suit 701 of 2022 lapses as the entire dispute is referred for resolution through arbitration in accordance with the Agreement/Contract between the parties the subject of which can only return to this Court for appellate or supervisory interventions as provided for under the Arbitration and Conciliation Act.
$\mathsf{Z}$
Further, costs occasioned by commencing the suit in this Court shall be determined by the arbitral tribunal appointed to handle the arbitration proceedings and the said issue of costs is accordingly referred to it.
Having held as I have above, I do not find it necessary to address the other issue raised by the Respondents at this point.
This file shall be closed accordingly.
montale.
HON. LADY JUSTICE ANNA B. MUGENYI DATED....................................
Case-aware research
Ask AI about this case
The judgment and available research above are public. New questions open in a separate private conversation grounded in this case.